This study is investigating a treatment called **human menopausal gonadotropin (hMG)** for women who have trouble getting pregnant, known as infertility. The study will look at how well the treatment works in helping women develop eggs, get pregnant, and have a live birth using a process called **Assisted Reproductive Technology (ART)**, which includes steps like in vitro fertilization (IVF) and **frozen embryo transfer (FET)**. **Key Points**: 1. **Eligibility**: Women aged 18-42, with specific health criteria, including hormone levels and normal reproductive organ conditions, may qualify. 2. **Commitments**: Participants should be willing to undergo up to two treatment cycles and manage some medications themselves. 3. **Exclusions**: Certain health conditions, lifestyle choices (like smoking), and previous pregnancy challenges may disqualify participants. If you're considering joining, you'll be part of a controlled study, meaning some will receive the treatment while others may get a placebo (a harmless pill with no effect). It's important to discuss with your doctor to see if you're a good fit and understand the potential risks and benefits.